Medical research

Ide-cel beneficial in relapsed, refractory multiple myeloma

For patients with pretreated relapsed and refractory multiple myeloma, idecabtagene vicleucel (ide-cel), a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, prolongs progression-free survival and ...

Oncology & Cancer

Body mass index tied to multiple myeloma survival

Underweight and severe obesity are associated with decreased survival in patients with multiple myeloma (MM), according to a study published online Jan. 12 in the Blood Cancer Journal.

Oncology & Cancer

Quality of treatment for lung cancer varies widely across US

Treatment for lung cancer is rapidly evolving, with new technologies and research-proven procedures. However, a study from Washington University School of Medicine in St. Louis found the quality of care for lung cancer in ...

Cardiology

Calling patients after heart failure may save lives

Phone calls from a nurse may improve survival for patients treated for heart failure, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.

page 12 from 40